Posts by John

Discover how Operation Trailblazer aims to revitalize U.S. clinical trials, improve patient enrollment, and accelerate life-saving medical innovation.

A new clinical trial is underway to test two experimental drugs against a fast-growing Ebola outbreak, aiming to improve patient survival rates globally.

A breakthrough study on a new GLP-1 drug reveals significant, sustainable weight loss results, offering a promising future for obesity and metabolic care.

The HHS is fast-tracking early-stage drug research to boost domestic innovation and counter global competition. Learn how this shift impacts biotech.

The HHS has unveiled a new national strategy to modernize clinical trials, focusing on decentralization, improved data sharing, and increased diversity.

A new investigational drug from UC San Diego shows potential to improve cholesterol management, offering hope for patients with statin intolerance.

Samsung and Alcedis are partnering to integrate wearable biometric data into clinical trials, advancing the use of real-world evidence in drug development.

Samsung partners with Alcedis to bridge the gap between wearable health data and clinical trial evidence, enhancing remote monitoring and data accuracy.

A new clinical trial shows a promising drug outperforms standard treatments in preventing kidney transplant rejection. Read the latest on this breakthrough.

Viking Therapeutics has launched a Phase 1 trial for VK3019, a novel amylin receptor agonist targeting metabolic disorders. Learn about this new development.